Not logged in CD8+Tcells in the tumor microenvironment modulate the response to endocrine therapy in breast cancer Napolitano, Fabiana; Wang, Yunguan; Sudhan, Dhivya R.; Gonzalez-Ericsson, Paula I.; Formisano, Luigi; Unni, Nisha; Shakeel, Shahbano; Zhu, James Z.; Ahuja, Khushi; Guo, Lei; Chica-Parrado, Maria Rosario; Matsunaga, Yuki; Luna, Pamela; Lin, Chang-Ching A.; Uemoto, Yasuaki; Lee, Kyung-Min; Ma, Hongli; Evans, Nathaniel J.; Servetto, Alberto; Mendiratta, Saurabh; Barnes, Spencer D.; Bianco, Roberto; V. Fang, Yisheng; Xu, Lin; Lee, Jeon; Wang, Tao; Balko, Justin M.; Mills, Gordon B.; Labrie, Marilyne; Hanker, Ariella B.; Arteaga, Carlos L. Share Save
Corrigendum to “Combined inhibition of CDK4/6 and AKT is highly effective against the luminal androgen receptor (LAR) subtype of triple negative breast cancer” [604 (2024) 217219 1–12] Chica-Parrado, Maria Rosario; Kim, Gun Min; Uemoto, Yasuaki; Napolitano, Fabiana; Lin, Chang-Ching; Ye, Dan; Bikorimana, Emmanuel; Fang, Yisheng; Lee, Kyung-min; Mendiratta, Saurabh; Hanker, Ariella B.; Arteaga, Carlos L. Share Save
Share Save
Share Save
Selective degradation of FGFR1/2 overcomes antiestrogen resistance in ER+ breast cancer with FGFR1/2 alterations (vol 619, 217668, 2025) Uemoto, Yasuaki; Lin, Chang-Ching A.; Wang, Bingnan; Ye, Dan; Fang, Yisheng, V; Bikorimana, Emmanuel; Napolitano, Fabiana; Chica-Parrado, Maria Rosario; Li, Cheung; Mendiratta, Saurabh; Chen, Chuo; Hanker, Ariella B.; Arteaga, Carlos L. Share Save
Prognostic Utility of ctDNA Detection in The monarchE Trial of Adjuvant Abemaciclib Plus Endocrine therapy (ET) in HR+, HER2-, Node-positive, High-risk Early Breast Cancer (EBC) Loi, S.; Johnston, S.; Arteaga, C.; Graff, S.; Chandarlapaty, S.; Goetz, M.; Desmedt, C.; Sasano, H.; Liu, D.; Rodrik-Outmezguine, V.; Sireci, A.; Sandoval, C.; Won, H.; Litchfield, L.; Turner, N. Share Save
Genomic And Transcriptomic Profiling of Primary Tumors From Patients with HR+, HER2-, Node-positive, High-risk Early Breast Cancer (EBC) in the monarchE Trial Rubenstein, C. S.; Turner, N.; Reis-Filho, J. S.; Goetz, M. P.; Desmedt, C.; Chandarlapaty, S.; Sasano, H.; Arteaga, C. L.; Loi, S.; Graff, S. L.; Liu, D.; Rodrik-Outmezguine, V.; Sireci, A.; Won, H.; Litchfield, L. M.; Munoz, M.; Johnston, S. Share Save
Acquired gene alterations in patients treated with ribociclib plus endocrine therapy or endocrine therapy alone using baseline and end-of-treatment circulating tumor DNA samples in the MONALEESA-2,-3, and-7 trials Andre, F.; Solovieff, N.; Su, F.; Bardia, A.; Neven, P.; Yap, Y. S.; Tripathy, D.; Lu, Y. -S.; Slamon, D.; Chia, S.; Joshi, M.; Chakravartty, A.; Lteif, A.; Taran, T.; Arteaga, C. L. Share Save
Combined inhibition of CDK4/6 and AKT is highly effective against the luminal androgen receptor (LAR) subtype of triple negative breast cancer Chica-Parrado, Maria Rosario; Kim, Gun Min; Uemoto, Yasuaki; Napolitano, Fabiana; Lin, Chang-Ching; Ye, Dan; Bikorimana, Emmanuel; Fang, Yisheng; Lee, Kyung-min; Mendiratta, Saurabh; Hanker, Ariella B.; Arteaga, Carlos L. Share Save
Share Save
Mapping cellular interactions from spatially resolved transcriptomics data Zhu, James; Wang, Yunguan; Chang, Woo Yong; Malewska, Alicia; Napolitano, Fabiana; Gahan, Jeffrey C.; Unni, Nisha; Zhao, Min; Yuan, Rongqing; Wu, Fangjiang; Yue, Lauren; Guo, Lei; Zhao, Zhuo; Chen, Danny Z.; Hannan, Raquibul; Zhang, Siyuan; Xiao, Guanghua; Mu, Ping; Hanker, Ariella B.; Strand, Douglas; Arteaga, Carlos L.; Desai, Neil; Wang, Xinlei; Xie, Yang; Wang, Tao Share Save
A randomized phase III double-blind placebo-controlled trial of first-line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105) Mezzanotte-Sharpe, Jessica; ONeill, Anne; Mayer, Ingrid A.; Arteaga, Carlos L.; Yang, Ximing J.; Wagner, Lynne I.; Cella, David; Meropol, Neal J.; Alpaugh, R. Katherine; Saphner, Thomas J.; Swaney, Robert E.; Hoelzer, Karen L.; Gradishar, William J.; Abramson, Vandana G.; Sundaram, P. Kothai; Jilani, Shamim Z.; Perez, Edith A.; Lin, Nancy U.; Jahanzeb, Mohammad; Wolff, Antonio C.; Sledge, George W.; Reid, Sonya A. Share Save
Share Save
Targeting LIPA independent of its lipase activity is a therapeutic strategy in solid tumors via induction of endoplasmic reticulum stress (vol 3, pg 866, 2022) Liu, Xihui; Viswanadhapalli, Suryavathi; Kumar, Shourya; Lee, Tae-Kyung; Moore, Andrew; Ma, Shihong; Chen, Liping; Hsieh, Michael; Li, Mengxing; Sareddy, Gangadhara R.; Parra, Karla; Blatt, Eliot B.; Reese, Tanner C.; Zhao, Yuting; Chang, Annabel; Yan, Hui; Xu, Zhenming; Pratap, Uday P.; Liu, Zexuan; Roggero, Carlos M.; Tan, Zhenqiu; Weintraub, Susan T.; Peng, Yan; Tekmal, Rajeshwar R.; Arteaga, Carlos L.; Lippincott-Schwartz, Jennifer; Vadlamudi, Ratna K.; Ahn, Jung-Mo; Raj, Ganesh V. Share Save
A bedside-to-bench translational analysis demonstrates that NF1 alterations promote CDK4/6 inhibitor (CDK4/6i) resistance in hormone receptor-positive (HR plus ) metastatic breast cancer (MBC) Lloyd, Maxwell; Chica-Parrado, M. Rosario; Knepper, Todd; Lin, Chang-Ching; Podany, Emily; Walko, Christine; Napolitano, Fabiana; Weipert, Caroline; Liao, Jiemin; Medford, Arielle; Ryan, Lianne; Keenan, Jennifer; Zhang, Nicole; Liu, Shiyuan; Wulf, Gerburg; Clifton, Katherine; Ma, Cynthia; Han, Hyo; Ellisen, Leif; Bardia, Aditya; Arteaga, Carlos; Hanker, Ariella; Wander, Seth Share Save
Tumor immune microenvironment modulates resistance to estrogen suppression in ER plus breast cancer Napolitano, Fabiana; Wang, Yunguan; Sudhan, Dhivya; Gonzalez-Ericsson, Paula; Formisano, Luigi; Guo, Lei; Chica-Parrado, M. Rosario; Lin, Chang-Ching; Lee, Kyung-Min; Ma, Hongli; Evans, Nathaniel; Servetto, Alberto; Mendiratta, Saurabh; Barnes, Spencer; Fang, Yisheng; Xu, Lin; Balko, Justin; Mills, Gordon; Labrie, Marilyne; Hanker, Ariella; Arteaga, Carlos Share Save
Results from a pilot study exploring ctDNA detection using a tumor-informed assay in the monarchE trial of adjuvant abemaciclib with endocrine therapy in HR+, HER2-, node-positive, high-risk early breast cancer Loi, Sherene; Johnston, Stephen; Arteaga, Carlos; Graff, Stephanie; Chandarlapaty, Sarat; Goetz, Matthew; Desmedt, Christine; Reis-Filho, Jorge; Sasano, Hironobu; Rodrik-Outmezguine, Vanessa; Sireci, Anthony; Rubenstein, Cynthia Sandoval; Won, Helen; Liu, Deli; Litchfield, Lacey M.; Turner, Nicholas Share Save
ESR1 mutations drive resistance to CDK4/6 inhibitors in ER plus Breast Cancer Chica-Parrado, M. Rosario; Lin, Chang-Ching; Jaeger, Ellen; Harris, Michelle; Guo, Lei; Bikorimana, Emmanuel; Napolitano, Fabiana; Chao, Calvin; Hanker, Ariella; Arteaga, Carlos Share Save
Phase I trial of pegylated liposomal doxorubicin chemotherapy in combination with CD40 agonist and Flt3 ligand in metastatic triple-negative breast cancer Reddy, Sangeetha; O'Shaughnessy, Joyce; Sadeghi, Navid; Syed, Samira; Santa-Maria, Cesar; Kaklamani, Virginia; Chen, Nan; Yardley, Denise; Fang, Yisheng; Chan, Isaac; Unni, Nisha; Kashanian, Sarah; Peswani, Namrata; Shakeel, Shahbano; Carter, Meredith; Kyle, Kelly; Fattah, Farjana; Ahn, Chul; Patel, Ina; Gruber, Joshua; Klemow, Dawn; Delgado, Glenda; Sinclair, Nicole; Yellin, Michael; McArthur, Heather; Nanda, Rita; Conzen, Suzanne; Arteaga, Carlos Share Save
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
